Breaking News, Collaborations & Alliances

Boehringer Ingelheim, Xencor in Biosuperiors Pact

BI to provide antibody manufacturing through Phase I

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Xencor, Inc. and Boehringer Ingelheim have entered a collaboration agreement for certain Xencor biosuperior monoclonal antibodies. BI will provide all manufacturing and product supply from preclinical through Phase I development. Xencor is responsible for preclinical and clinical studies and retains all development and commercial rights to products. For clinical programs beyond Phase I, BI has certain manufacturing rights to supply clinical and commercial material to Xencor. “Xencor has d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters